SK Bioscience Co Ltd
KRX:302440
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
45 950
73 300
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
SK Bioscience Co Ltd
Cash Flow Statement
Cash Flow Statement
SK Bioscience Co Ltd
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
32 890
|
74 815
|
127 626
|
181 052
|
355 139
|
341 021
|
334 335
|
278 676
|
122 452
|
80 378
|
18 276
|
45 890
|
22 318
|
22 868
|
27 435
|
|
| Depreciation & Amortization |
16 527
|
20 900
|
25 398
|
18 015
|
18 775
|
20 206
|
22 146
|
24 462
|
27 236
|
29 702
|
31 789
|
33 517
|
34 765
|
35 624
|
36 175
|
|
| Other Non-Cash Items |
8 612
|
22 568
|
(68 779)
|
58 545
|
130 619
|
113 100
|
218 725
|
85 401
|
36 221
|
24 420
|
(14 689)
|
42 307
|
7 969
|
(1 503)
|
(247)
|
|
| Cash Taxes Paid |
249
|
2 596
|
5 977
|
8 627
|
8 987
|
51 623
|
104 019
|
103 301
|
104 210
|
68 261
|
24 759
|
23 172
|
25 639
|
17 209
|
4 365
|
|
| Cash Interest Paid |
4 055
|
5 037
|
5 866
|
3 717
|
3 407
|
3 151
|
3 010
|
2 949
|
2 681
|
2 403
|
2 201
|
1 602
|
1 397
|
1 163
|
927
|
|
| Change in Working Capital |
62 195
|
156 877
|
176 416
|
23 555
|
32 060
|
(243 385)
|
(357 673)
|
(219 631)
|
(310 868)
|
(182 266)
|
(159 119)
|
(110 101)
|
(35 705)
|
14 314
|
71 813
|
|
| Cash from Operating Activities |
120 224
N/A
|
275 160
+129%
|
260 661
-5%
|
281 168
+8%
|
536 594
+91%
|
230 943
-57%
|
217 533
-6%
|
168 908
-22%
|
(124 958)
N/A
|
(47 766)
+62%
|
(123 743)
-159%
|
11 613
N/A
|
29 346
+153%
|
71 302
+143%
|
135 175
+90%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(10 198)
|
(16 182)
|
(25 882)
|
(31 154)
|
(44 470)
|
(62 088)
|
(85 003)
|
(87 287)
|
(76 489)
|
(60 150)
|
(38 687)
|
(44 482)
|
(50 295)
|
(118 350)
|
(117 459)
|
|
| Other Items |
(97 895)
|
(1 197 030)
|
(1 155 395)
|
(1 141 247)
|
(1 377 471)
|
(10 138)
|
(76 044)
|
(63 501)
|
349 136
|
222 862
|
396 108
|
280 642
|
5 017
|
(985)
|
(41 261)
|
|
| Cash from Investing Activities |
(108 093)
N/A
|
(1 213 212)
-1 022%
|
(1 181 278)
+3%
|
(1 172 401)
+1%
|
(1 421 940)
-21%
|
(72 226)
+95%
|
(161 046)
-123%
|
(150 789)
+6%
|
272 647
N/A
|
162 712
-40%
|
357 421
+120%
|
236 160
-34%
|
(45 279)
N/A
|
(119 335)
-164%
|
(158 720)
-33%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
0
|
984 196
|
983 256
|
983 256
|
983 256
|
(30)
|
2 618
|
2 618
|
2 618
|
0
|
0
|
0
|
398
|
0
|
0
|
|
| Net Issuance of Debt |
(1 237)
|
(24 260)
|
(24 801)
|
(24 042)
|
(24 247)
|
(2 298)
|
35 283
|
(14 509)
|
(22 485)
|
(69 821)
|
(147 934)
|
(100 966)
|
(95 464)
|
29 953
|
67 882
|
|
| Other |
(301)
|
(929)
|
(930)
|
(930)
|
(628)
|
0
|
0
|
0
|
0
|
0
|
5 484
|
5 484
|
5 484
|
0
|
0
|
|
| Cash from Financing Activities |
(1 539)
N/A
|
959 006
N/A
|
957 526
0%
|
958 284
+0%
|
958 380
+0%
|
(2 328)
N/A
|
37 901
N/A
|
(11 891)
N/A
|
(19 867)
-67%
|
(68 112)
-243%
|
(142 450)
-109%
|
(95 482)
+33%
|
(89 583)
+6%
|
35 835
N/A
|
68 280
+91%
|
|
| Change in Cash | ||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
22
|
21
|
39
|
0
|
(562)
|
4 096
|
6 826
|
7 692
|
7 253
|
4 441
|
3 084
|
|
| Net Change in Cash |
10 592
N/A
|
20 954
+98%
|
36 909
+76%
|
67 050
+82%
|
73 056
+9%
|
156 410
+114%
|
94 427
-40%
|
6 228
-93%
|
127 259
+1 943%
|
50 929
-60%
|
98 055
+93%
|
159 984
+63%
|
(98 262)
N/A
|
(7 757)
+92%
|
47 819
N/A
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
110 026
N/A
|
258 978
+135%
|
234 779
-9%
|
250 014
+6%
|
492 124
+97%
|
168 855
-66%
|
132 530
-22%
|
81 620
-38%
|
(201 448)
N/A
|
(107 916)
+46%
|
(162 430)
-51%
|
(32 869)
+80%
|
(20 949)
+36%
|
(47 048)
-125%
|
17 716
N/A
|
|
You don't have any saved screeners yet
